Literature DB >> 11999977

D-2-Hydroxyglutaric aciduria in a patient with a severe clinical phenotype and unusual MRI findings.

M Wajne1, C R Vargas, C Funayama, A Fernandez, M L C Elias, S I Goodman, C Jakobs, M S van der Knaap.   

Abstract

We report an infant with intermittent urinary excretion of D-2-hydroxyglutaric (D-2-OHG) acid who died at the age of 10 months from cardiogenic shock due to cardiomyopathy. High urinary concentrations of D-2-OHG and succinic acid, as well as increased levels of lactic acid were detected on three different occasions, whereas a normal urinary profile of organic acids was found on one occasion. The clinical findings of our patient consisted of generalized hypotonia, irritability, developmental delay, generalized tonic seizures, lethargy, cardiomyopathy, and respiratory distress. Cerebral MRI revealed bilateral lesions in the substantia nigra, the periaqueductal area, the medial part of the thalamus, the hypothalamus, the caudate nucleus, putamen and globus pallidus. This pattern is suggestive of a mitochondriopathy. However, respiratory chain enzyme activities were normal in fibroblasts. Exogenous supplementation of D-2-OHG acid strongly inhibited cytochrome-c oxidase activity in fibroblasts from the patient and from normal controls in vitro. The results suggest that our patient has an unusual form of D-2-hydroxyglutaric aciduria (D-2-OHGA), different from the patients published so far, and that the increase of lactic acid and some citric acid cycle intermediates encountered in some patients with D-2-OHGA may be due to a functional defect of the respiratory chain caused by D-2-OHG acid.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11999977     DOI: 10.1023/a:1015165212965

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  11 in total

1.  D-2-hydroxyglutaric aciduria: further clinical delineation.

Authors:  M S van der Knaap; C Jakobs; G F Hoffmann; M Duran; A C Muntau; S Schweitzer; R I Kelley; F Parrot-Roulaud; J Amiel; P De Lonlay; D Rabier; O Eeg-Olofsson
Journal:  J Inherit Metab Dis       Date:  1999-06       Impact factor: 4.982

2.  D-2-hydroxyglutaric aciduria in a newborn with neurological abnormalities: a new neurometabolic disorder?

Authors:  K M Gibson; W Craigen; G E Herman; C Jakobs
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

3.  D-2-hydroxyglutaric aciduria: case report and biochemical studies.

Authors:  R A Chalmers; A M Lawson; R W Watts; A S Tavill; J P Kamerling; E Hey; D Ogilvie
Journal:  J Inherit Metab Dis       Date:  1980       Impact factor: 4.982

4.  Inhibition of cytochrome c oxidase activity in rat cerebral cortex and human skeletal muscle by D-2-hydroxyglutaric acid in vitro.

Authors:  Cleide G da Silva; César A J Ribeiro; Guilhian Leipnitz; Carlos S Dutra-Filho; Angela T S Wyse AT; Clóvis M D Wannmacher; João J F Sarkis; Cornelis Jakobs; Moacir Wajner
Journal:  Biochim Biophys Acta       Date:  2002-01-02

5.  Differential investigation of the capacity of succinate oxidation in human skeletal muscle.

Authors:  J C Fischer; W Ruitenbeek; J A Berden; J M Trijbels; J H Veerkamp; A M Stadhouders; R C Sengers; A J Janssen
Journal:  Clin Chim Acta       Date:  1985-11-29       Impact factor: 3.786

Review 6.  Physiology and pathophysiology of organic acids in cerebrospinal fluid.

Authors:  G F Hoffmann; W Meier-Augenstein; S Stöckler; R Surtees; D Rating; W L Nyhan
Journal:  J Inherit Metab Dis       Date:  1993       Impact factor: 4.982

7.  Identification of the D-enantiomer of 2-hydroxyglutaric acid in glutaric aciduria type II.

Authors:  H Watanabe; S Yamaguchi; K Saiki; N Shimizu; T Fukao; N Kondo; T Orii
Journal:  Clin Chim Acta       Date:  1995-07-14       Impact factor: 3.786

Review 8.  Neurological manifestations of organic acid disorders.

Authors:  G F Hoffmann; K M Gibson; F K Trefz; W L Nyhan; H J Bremer; D Rating
Journal:  Eur J Pediatr       Date:  1994       Impact factor: 3.183

9.  Stable-isotope dilution analysis of D- and L-2-hydroxyglutaric acid: application to the detection and prenatal diagnosis of D- and L-2-hydroxyglutaric acidemias.

Authors:  K M Gibson; H J ten Brink; D S Schor; R M Kok; A H Bootsma; G F Hoffmann; C Jakobs
Journal:  Pediatr Res       Date:  1993-09       Impact factor: 3.756

10.  D-2-hydroxyglutaric aciduria.

Authors:  W L Nyhan; G D Shelton; C Jakobs; B Holmes; C Bowe; C J Curry; C Vance; M Duran; L Sweetman
Journal:  J Child Neurol       Date:  1995-03       Impact factor: 1.987

View more
  10 in total

1.  Mitochondrial Citrate Transporter-dependent Metabolic Signature in the 22q11.2 Deletion Syndrome.

Authors:  Eleonora Napoli; Flora Tassone; Sarah Wong; Kathleen Angkustsiri; Tony J Simon; Gyu Song; Cecilia Giulivi
Journal:  J Biol Chem       Date:  2015-07-28       Impact factor: 5.157

Review 2.  D-2-Hydroxyglutaric aciduria: unravelling the biochemical pathway and the genetic defect.

Authors:  Eduard A Struys
Journal:  J Inherit Metab Dis       Date:  2006-02       Impact factor: 4.982

3.  2-Hydroxyglutarate Inhibits ATP Synthase and mTOR Signaling.

Authors:  Xudong Fu; Randall M Chin; Laurent Vergnes; Heejun Hwang; Gang Deng; Yanpeng Xing; Melody Y Pai; Sichen Li; Lisa Ta; Farbod Fazlollahi; Chuo Chen; Robert M Prins; Michael A Teitell; David A Nathanson; Albert Lai; Kym F Faull; Meisheng Jiang; Steven G Clarke; Timothy F Cloughesy; Thomas G Graeber; Daniel Braas; Heather R Christofk; Michael E Jung; Karen Reue; Jing Huang
Journal:  Cell Metab       Date:  2015-07-16       Impact factor: 27.287

Review 4.  Disruption of mitochondrial homeostasis in organic acidurias: insights from human and animal studies.

Authors:  Moacir Wajner; Stephen I Goodman
Journal:  J Bioenerg Biomembr       Date:  2011-02       Impact factor: 2.945

5.  Child with D-2-Hydroxyglutaric Aciduria Type II: A Rare Neurometabolic Disorder.

Authors:  Rangan Srinivasaraghavan; Suvasini Sharma; Lisa Kratz; Prateek Malik; Sangeetha Yoganathan; Sumita Danda; Samuel Philip Oommen
Journal:  Ann Indian Acad Neurol       Date:  2021-12-17       Impact factor: 1.383

6.  Inhibition of mitochondrial creatine kinase activity by D-2-hydroxyglutaric acid in cerebellum of young rats.

Authors:  Cleide G da Silva; Ana Rubia F Bueno; Rafael B Rosa; Carlos S Dutra Filho; Clovis M D Wannmacher; Angela T S Wyse; Moacir Wajner
Journal:  Neurochem Res       Date:  2003-09       Impact factor: 3.996

Review 7.  Progress in understanding 2-hydroxyglutaric acidurias.

Authors:  Martijn Kranendijk; Eduard A Struys; Gajja S Salomons; Marjo S Van der Knaap; Cornelis Jakobs
Journal:  J Inherit Metab Dis       Date:  2012-03-06       Impact factor: 4.982

8.  Isocitrate dehydrogenase 1 and 2 mutations induce BCL-2 dependence in acute myeloid leukemia.

Authors:  Steven M Chan; Daniel Thomas; M Ryan Corces-Zimmerman; Seethu Xavy; Suchita Rastogi; Wan-Jen Hong; Feifei Zhao; Bruno C Medeiros; David A Tyvoll; Ravindra Majeti
Journal:  Nat Med       Date:  2015-01-19       Impact factor: 87.241

9.  Computational approach to unravel the impact of missense mutations of proteins (D2HGDH and IDH2) causing D-2-hydroxyglutaric aciduria 2.

Authors:  D Thirumal Kumar; L Jerushah Emerald; C George Priya Doss; P Sneha; R Siva; W Charles Emmanuel Jebaraj; Hatem Zayed
Journal:  Metab Brain Dis       Date:  2018-07-09       Impact factor: 3.655

Review 10.  Metabolic consequences of oncogenic IDH mutations.

Authors:  Seth J Parker; Christian M Metallo
Journal:  Pharmacol Ther       Date:  2015-05-05       Impact factor: 13.400

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.